Poly(Lactic-co-Glycolic) Acid as a Carrier for Imaging Contrast Agents

PurposeWith the broadening field of nanomedicine poised for future molecular level therapeutics, nano- and microparticles intended for the augmentation of either single- or multimodal imaging are created with PLGA as the chief constituent and carrier.MethodsEmulsion techniques were used to encapsulate hydrophilic and hydrophobic imaging contrast agents in PLGA particles. The imaging contrast properties of these PLGA particles were further enhanced by reducing silver onto the PLGA surface, creating a silver cage around the polymeric core.ResultsThe MRI contrast agent Gd-DTPA and the exogenous dye rhodamine 6G were both encapsulated in PLGA and shown to enhance MR and fluorescence contrast, respectively. The silver nanocage built around PLGA nanoparticles exhibited strong near infrared light absorbance properties, making it a suitable contrast agent for optical imaging strategies such as photoacoustic imaging.ConclusionsThe biodegradable polymer PLGA is an extremely versatile nano- and micro-carrier for several imaging contrast agents with the possibility of targeting diseased states at a molecular level.

[1]  D. Brett.  A discussion of silver as an antimicrobial agent: alleviating the confusion. , 2006, Ostomy/wound management.

[2]  M. L. Ferreira,et al.  PLA nano- and microparticles for drug delivery: an overview of the methods of preparation. , 2007, Macromolecular bioscience.

[3]  Klaas Nicolay,et al.  MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[5]  L. Brannon-Peppas,et al.  Optimization of Preparation Techniques for Poly(Lactic Acid-Co-Glycolic Acid) Nanoparticles , 2000 .

[6]  R. Kruger,et al.  Photoacoustic ultrasound (PAUS)--reconstruction tomography. , 1995, Medical physics.

[7]  Suming Li,et al.  Recent advances in the field of lactic acid/glycolic acid polymer-based therapeutic systems , 1995 .

[8]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[9]  A. R.,et al.  Review of literature , 1951, American Potato Journal.

[10]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  Xu Xiao.  Photoacoustic imaging in biomedicine , 2008 .

[12]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[13]  N. Stanietsky,et al.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[14]  R. Weissleder,et al.  In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. , 2005, Bioconjugate chemistry.

[15]  X. J. Zhang,et al.  Integrated system for ultrasonic, photoacoustic and elasticity imaging , 2006, SPIE Medical Imaging.

[16]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Lisa Brannon-Peppas,et al.  Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. , 2007, Nanomedicine.

[18]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[19]  Barjor Gimi,et al.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods , 2005, Proceedings of the IEEE.

[20]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[21]  V. Fuster,et al.  Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.

[22]  Lisa Brannon-Peppas,et al.  Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI , 2008, Proceedings of the National Academy of Sciences.

[23]  Y. Y. Yang,et al.  Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form. , 2003, Journal of microencapsulation.

[24]  R L Reis,et al.  Materials in particulate form for tissue engineering. 1. Basic concepts , 2007, Journal of tissue engineering and regenerative medicine.

[25]  C. Astete,et al.  Synthesis and characterization of PLGA nanoparticles , 2006, Journal of biomaterials science. Polymer edition.

[26]  R. Langer,et al.  Biodegradable polymers as drug delivery systems , 1990 .

[27]  L. Zhao.  Biodegradable polymers as drug delivery systems , 2004 .

[28]  Martin Frenz,et al.  Combined ultrasound and optoacoustic system for real-time high-contrast vascular imaging in vivo , 2005, IEEE Transactions on Medical Imaging.

[29]  D. Seligson,et al.  Pin tract infections: silver vs uncoated pins. , 1994, Orthopedics.

[30]  E. McVeigh,et al.  In vitro release of vascular endothelial growth factor from gadolinium‐doped biodegradable microspheres , 2004, Magnetic resonance in medicine.

[31]  G. Ruggeri,et al.  Photoinduced formation of gold nanoparticles into vinyl alcohol based polymers , 2006 .

[32]  Xiaoping Hu,et al.  Long‐circulating liposomal contrast agents for magnetic resonance imaging , 2006, Magnetic resonance in medicine.

[33]  M. Alonso,et al.  Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  G. Pulverer,et al.  Efficacy of silver-coated medical devices. , 1998, The Journal of hospital infection.

[35]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[36]  Lisbeth Illum,et al.  Polymers in Controlled Drug Delivery , 1988 .

[37]  S. Laurent,et al.  Gadolinium DTPA-Monoamide Complexes Incorporated into Mixed Micelles as Possible MRI Contrast Agents , 2004 .

[38]  Bishara S Atiyeh,et al.  Effect of silver on burn wound infection control and healing: review of the literature. , 2007, Burns : journal of the International Society for Burn Injuries.

[39]  P. S. Jarrett,et al.  Antibacterial Silver , 1994, Metal-based drugs.

[40]  Qi Zhou,et al.  A Tumor-Targeted Nanodelivery System to Improve Early MRI Detection of Cancer , 2006, Molecular imaging.

[41]  Ruxandra Gref,et al.  Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. , 1998, Journal of biomedical materials research.

[42]  Si-Shen Feng,et al.  Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. , 2004, Current medicinal chemistry.

[43]  H. Ichikawa,et al.  Chitosan-Gadopentetic Acid Complex Nanoparticles for Gadolinium Neutron-Capture Therapy of Cancer: Preparation by Novel Emulsion-Droplet Coalescence Technique and Characterization , 1999, Pharmaceutical Research.

[44]  W. Winkelmann,et al.  Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects. , 2004, Biomaterials.

[45]  L. Brannon-Peppas,et al.  Rhodamine-loaded poly(lactic-co-glycolic acid) nanoparticles for investigation of in vitro interactions with breast cancer cells , 2009, Journal of materials science. Materials in medicine.

[46]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[47]  R. Reis,et al.  Materials in particulate form for tissue engineering. 2. Applications in bone , 2007, Journal of tissue engineering and regenerative medicine.